AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Acute Myeloid Leukemia (AML) in Remission

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Suning Chen, PhD) · chensuning@sina.com · +8613814881746
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, Jiangsu, China
Contact: Study coordinator (Suning Chen, Professor) · chensuning@sina.com · 13814881746
Contact: Principal Investigator (Suning Chen, Professor)

Study leads

Suning Chen
Principal Investigator
First Affiliated Hospital of Soochow University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML

AML, Childhood · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Hefei, China · Hefei, China

The Maintenance Treatment of "ITIVA" in AML Patients

Acute Myeloid Leukemia · Maintenance Treatment · Minor Residue Disease

Abroad (travel likely)Recruiting

Zhengzhou, China

Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML

Acute Myeloid Leukemia

Abroad (travel likely)Recruiting

Nanjing, China

Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

Acute Lymphoblastic Leukemia (ALL) in Complete Remission · Acute Myeloid Leukemia (AML) in Remission

Abroad (travel likely)RecruitingPHASE3

Riyadh, Saudi Arabia